Clinical trial
Phase II Trial With Safety-Run-In of MEK Inhibitor MSC1936369B in Subjects With Poor Prognosis Acute Myeloid Leukemia and Other Hematological Malignancies
NCT00957580 is registered in ClinicalTrials.gov with EMD Serono as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Trial With Safety-Run-In of MEK Inhibitor MSC1936369B in Subjects With Poor Prognosis Acute Myeloid Leukemia and Other Hematological Malignancies
- Lead sponsor
- EMD Serono
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- September 30, 2009
- Completion date
- December 31, 2012
- Enrollment
- 81 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.